-
Je něco špatně v tomto záznamu ?
Pathophysiological characteristics of non-alcoholic steatohepatitis-like changes in cholesterol-loaded type 2 diabetic rats
Y. Toriniwa, M. Muramatsu, Y. Ishii, E. Riya, K. Miyajima, S. Ohshida, K. Kitatani, S. Takekoshi, T. Matsui, S. Kume, T. Yamada, T. Ohta
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- cholesterol dietní aplikace a dávkování škodlivé účinky MeSH
- diabetes mellitus 2. typu krev patofyziologie MeSH
- krysa rodu rattus MeSH
- nealkoholová steatóza jater krev etiologie patofyziologie MeSH
- potkani Sprague-Dawley MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Spontaneously Diabetic Torii (SDT) fatty rats, a new obese diabetic model, reportedly presented with features of non-alcoholic steatohepatitis (NASH) after 32 weeks of age. We tried to accelerate the onset of NASH in SDT fatty rats using dietary cholesterol loading and noticed changes in the blood choline level which is expected to be a NASH biomarker. Body weight and biochemical parameters were measured from 8 to 24 weeks of age. At 16, 20, 24 weeks, pathophysiological analysis of the livers were performed. Hepatic lipids, lipid peroxides, and the expression of mRNA related to triglyceride (TG) synthesis, inflammation, and fibrosis were evaluated at 24 weeks. Hepatic fibrosis was observed in SDT fatty rats fed cholesterol-enriched diets (SDT fatty-Cho) from 16 weeks. Furthermore, hepatic lipids and lipid peroxide were significantly higher in SDT fatty-Cho than SDT fatty rats fed normal diets at 24 weeks. Hepatic mRNA expression related to TG secretion decreased in SDT fatty-Cho, and the mRNA expression related to inflammation and fibrosis increased in SDT fatty-Cho at 24 weeks. Furthermore, SDT fatty-Cho presented with increased plasma choline, similar to human NASH. There were no significant changes in the effects of feeding a cholesterol-enriched diet in Sprague-Dawley rats. SDT fatty-Cho has the potential to become a valuable animal model for NASH associated with type 2 diabetes and obesity.
Department of Agrobiology Faculty ofAgriculture Niigata University Nishi ku Niigata Japan
Japan Tobacco Inc Central Pharmaceutical Research Institute Murasaki cho Takatsuki Osaka Japan
Kyoto University Graduate School of Agriculture Kitashirakawa Sakyo ku Kyoto Japan
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19004008
- 003
- CZ-PrNML
- 005
- 20190208091451.0
- 007
- ta
- 008
- 190124s2018 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933784 $2 doi
- 035 __
- $a (PubMed)29750881
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Toriniwa, Y. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Murasaki-cho, Takatsuki, Osaka,Japan; Department of Agrobiology, Faculty ofAgriculture, Niigata University, Nishi-ku, Niigata, Japan
- 245 10
- $a Pathophysiological characteristics of non-alcoholic steatohepatitis-like changes in cholesterol-loaded type 2 diabetic rats / $c Y. Toriniwa, M. Muramatsu, Y. Ishii, E. Riya, K. Miyajima, S. Ohshida, K. Kitatani, S. Takekoshi, T. Matsui, S. Kume, T. Yamada, T. Ohta
- 520 9_
- $a Spontaneously Diabetic Torii (SDT) fatty rats, a new obese diabetic model, reportedly presented with features of non-alcoholic steatohepatitis (NASH) after 32 weeks of age. We tried to accelerate the onset of NASH in SDT fatty rats using dietary cholesterol loading and noticed changes in the blood choline level which is expected to be a NASH biomarker. Body weight and biochemical parameters were measured from 8 to 24 weeks of age. At 16, 20, 24 weeks, pathophysiological analysis of the livers were performed. Hepatic lipids, lipid peroxides, and the expression of mRNA related to triglyceride (TG) synthesis, inflammation, and fibrosis were evaluated at 24 weeks. Hepatic fibrosis was observed in SDT fatty rats fed cholesterol-enriched diets (SDT fatty-Cho) from 16 weeks. Furthermore, hepatic lipids and lipid peroxide were significantly higher in SDT fatty-Cho than SDT fatty rats fed normal diets at 24 weeks. Hepatic mRNA expression related to TG secretion decreased in SDT fatty-Cho, and the mRNA expression related to inflammation and fibrosis increased in SDT fatty-Cho at 24 weeks. Furthermore, SDT fatty-Cho presented with increased plasma choline, similar to human NASH. There were no significant changes in the effects of feeding a cholesterol-enriched diet in Sprague-Dawley rats. SDT fatty-Cho has the potential to become a valuable animal model for NASH associated with type 2 diabetes and obesity.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cholesterol dietní $x aplikace a dávkování $x škodlivé účinky $7 D002791
- 650 _2
- $a diabetes mellitus 2. typu $x krev $x patofyziologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nealkoholová steatóza jater $x krev $x etiologie $x patofyziologie $7 D065626
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Muramatsu, M. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Murasaki-cho, Takatsuki, Osaka,Japan
- 700 1_
- $a Ishii, Y. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Murasaki-cho, Takatsuki, Osaka,Japan
- 700 1_
- $a Riya, E. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Toxicology ResearchLaboratories, Naganuki, Hadano, Kanagawa, Japan
- 700 1_
- $a Miyajima, K. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Toxicology ResearchLaboratories, Naganuki, Hadano, Kanagawa, Japan
- 700 1_
- $a Ohshida, S. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Toxicology ResearchLaboratories, Naganuki, Hadano, Kanagawa, Japan
- 700 1_
- $a Kitatani, K. $u Department of Cell Biology, Division ofHost Defense Mechanism, Tokai University School of Medicine, Shimokasuya, Isehara, Kanagawa,Japan
- 700 1_
- $a Takekoshi, S. $u Department of Cell Biology, Division ofHost Defense Mechanism, Tokai University School of Medicine, Shimokasuya, Isehara, Kanagawa,Japan
- 700 1_
- $a Matsui, T. $u Kyoto University, Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto, Japan
- 700 1_
- $a Kume, S. $u Kyoto University, Graduate School of Agriculture, Kitashirakawa, Sakyo-ku, Kyoto, Japan
- 700 1_
- $a Yamada, T. $u Department of Agrobiology, Faculty ofAgriculture, Niigata University, Nishi-ku, Niigata, Japan
- 700 1_
- $a Ohta, T. $u Japan Tobacco Inc., Central Pharmaceutical Research Institute, Murasaki-cho, Takatsuki, Osaka,Japan
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 67, č. 4 (2018), s. 601-612
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29750881 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20190124 $b ABA008
- 991 __
- $a 20190206105528 $b ABA008
- 999 __
- $a ok $b bmc $g 1374797 $s 1042186
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 67 $c 4 $d 601-612 $e 20180510 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20190124